Indeed, Kim and co-workers also showed that mice whose tumors regressed were immune to subsequent challenge with unmodified tumors (i.e., not expressing C5a), suggesting that at least some of the effects of C5a were indirect, via enhancement of the anti-tumor immune response. This evidence concerns the gene C5AR1 and neoplasm.